cro.directory
← Compare landing

ITR Laboratories vs Oncodesign Services

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/itrlab/oncodesign-services

CategoryITR LaboratoriesOncodesign Services
Listed sitecrocro
SummaryGLP-compliant nonclinical CRO specializing in safety and toxicology testing across in silico, in vitro, and in vivo modalities, with 35+ years of experience and nearly 6,000 completed studies.Contract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995.
Services
  • GLP Toxicology
  • Safety Pharmacology
  • Genetic Toxicology
  • In Vitro ADME / DMPK
  • In Vitro Pharmacology
  • Preclinical In Vitro Studies
  • In Vivo PK / PD Studies
  • Preclinical In Vivo Studies
  • Pathology & Histology Services
  • Discovery Research
  • Target Identification & Validation
  • Medicinal Chemistry
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Specialized & Large-Animal Models
  • Bioanalysis
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Clinical Imaging Core Lab
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • Virology Services
  • GLP Toxicology
  • Safety Pharmacology
  • Translational Research
  • Preclinical In Vitro Studies
  • Regulatory Affairs
  • LC-MS Bioanalysis (Small Molecule)
  • High-Throughput Screening
  • Genetic Toxicology
  • Computational & In-Silico Drug Discovery
  • Carcinogenicity Studies
  • DART (Reproductive & Developmental Toxicology)
  • Flow Cytometry Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Ligand-Binding Bioanalysis (Large Molecule)
Modalities
  • Small Molecule
  • Biologics (Other)
  • Small Molecule
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Radiopharmaceutical
IndicationsData not yet provided.
  • Oncology
  • Immunology
  • Infectious Disease
  • Dermatology
  • Gastroenterology
  • Nephrology
  • Metabolic
  • Rare Disease
  • Respiratory
Locations
  • Headquarters, Baie-D'Urfe, Quebec, Canada
  • US Office, Cambridge, Massachusetts, USA
  • Headquarters, Dijon, Bourgogne-Franche-Comté, France
  • Headquarters
Certifications
  • AAALAC · Identifier: AAALAC accredited
  • CCAC · Identifier: CCAC accredited
  • FDA · Identifier: FDA inspected
  • EMA · Identifier: EMA inspected
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.